A proof of concept, phase II study of Ropivacaine Transdermal Patch for Neuropathic Pain.

Trial Profile

A proof of concept, phase II study of Ropivacaine Transdermal Patch for Neuropathic Pain.

Planning
Phase of Trial: Phase II

Latest Information Update: 19 May 2017

At a glance

  • Drugs Ropivacaine (Primary)
  • Indications Neuropathic pain; Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 May 2017 New trial record
    • 09 May 2017 According to a tesa Labtec media release, company is endeavoring to find a product partner in order to continue the development of this phase.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top